|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||28.73 - 29.79|
|52 Week Range||24.45 - 52.33|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 25, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||47.64|
The Medicines Company will host a conference call and audio webcast on Wednesday, April 25, 2018, at 8:30 a.m., Eastern Time, to discuss first-quarter 2018 financial results and operational developments.
Ironwood Pharmaceuticals told shareholders Monday that it's learned biotech activist investor Alex Denner of Sarissa Capital is seeking to join its board.
The Medicines Company today announced the appointment of Christopher Visioli as Chief Financial Officer and Treasurer of the Company, effective immediately. Mr. Visioli succeeds William B.
The Medicines Company (MDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
But what is clear is that in the not too distant future, PCSK9 inhibitors will be priced in a way that will be palatable to payers thereby making this class of important drugs available to those whose lives can be saved or prolonged by them.
The Medicines Company today announced that it will participate in the Oppenheimer 28th Annual Healthcare Conference on Tuesday, March 20, 2018, in New York City, NY. The Company is scheduled to present at 08:00 a.m., Eastern Time.
Esperion popped Monday after a study from Regeneron and Sanofi validated the long-term benefits of lowering LDL cholesterol.
Alnylam Pharmaceuticals (ALNY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Medicines Company today announced that randomization of more than 1,500 patients in the ORION-10 trial in the United States has been completed in only 12 weeks – considerably beating its goal of 22 weeks.
The Medicines Company today announced that it will participate in the Cowen 38th Annual Health Care Conference on Tuesday, March 13, 2018, in Boston, MA. The Company is scheduled to present at 10:00 a.m., Eastern Time.
Medicines Company said in a regulatory filing it was restructuring its board by reducing the number of members to 7 from 12. The company said it would nominate Denner, along with Fredric Eshelman, Geno Germano, John Kelly, Clive Meanwell, Paris Panayiotopoulos and Sarah J. Schlesinger to the board.
Medicines Company shares surged 6.2% in heavy morning trade on Thursday after the company reported plans to restructure its board and reduce the number of board members from 12 to seven in a financial ...